Luyan Pharma Co Ltd (002788) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥118.98 Million ≈ $17.41 Million USD) by net assets (CN¥3.26 Billion ≈ $477.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Luyan Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Luyan Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Luyan Pharma Co Ltd carry for a breakdown of total debt and financial obligations.

Luyan Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luyan Pharma Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sichuan Mingxing Electric Power Co Ltd SHG:600101	0.045x
Johns LYNG Group Ltd AU:JLG	0.096x
Tanla Platforms Limited NSE:TANLA	0.074x
Cera Sanitaryware Limited NSE:CERA	0.055x
Sudarshan Chemical Industries Limited NSE:SUDARSCHEM	-0.036x
Whirlpool S.A SA:WHRL3	-0.068x
Akasha Wira International Tbk JK:ADES	0.056x
Ferrari Group PLC AS:FERGR	0.078x

Annual Cash Flow Conversion Efficiency for Luyan Pharma Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Luyan Pharma Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002788 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.19 Billion ≈ $467.08 Million	CN¥577.48 Million ≈ $84.50 Million	0.181x	-58.86%
2023-12-31	CN¥2.98 Billion ≈ $435.62 Million	CN¥1.31 Billion ≈ $191.57 Million	0.440x	+428.54%
2022-12-31	CN¥2.79 Billion ≈ $408.36 Million	CN¥232.19 Million ≈ $33.98 Million	0.083x	+157.26%
2021-12-31	CN¥2.56 Billion ≈ $374.63 Million	CN¥-372.02 Million ≈ $-54.44 Million	-0.145x	-552.79%
2020-12-31	CN¥2.41 Billion ≈ $352.11 Million	CN¥77.22 Million ≈ $11.30 Million	0.032x	+109.63%
2019-12-31	CN¥1.89 Billion ≈ $276.28 Million	CN¥-629.14 Million ≈ $-92.06 Million	-0.333x	-534.66%
2018-12-31	CN¥1.65 Billion ≈ $241.97 Million	CN¥126.77 Million ≈ $18.55 Million	0.077x	+126.85%
2017-12-31	CN¥1.57 Billion ≈ $229.21 Million	CN¥-447.16 Million ≈ $-65.43 Million	-0.285x	-207.31%
2016-12-31	CN¥1.38 Billion ≈ $201.67 Million	CN¥-128.03 Million ≈ $-18.73 Million	-0.093x	-31699.60%
2015-12-31	CN¥746.00 Million ≈ $109.16 Million	CN¥219.31K ≈ $32.09K	0.000x	-99.89%
2014-12-31	CN¥649.30 Million ≈ $95.01 Million	CN¥177.89 Million ≈ $26.03 Million	0.274x	+299.88%
2013-12-31	CN¥557.87 Million ≈ $81.63 Million	CN¥-76.47 Million ≈ $-11.19 Million	-0.137x	-86.46%
2012-12-31	CN¥448.15 Million ≈ $65.58 Million	CN¥-32.94 Million ≈ $-4.82 Million	-0.074x	-193.16%
2011-12-31	CN¥354.91 Million ≈ $51.93 Million	CN¥28.01 Million ≈ $4.10 Million	0.079x	--

About Luyan Pharma Co Ltd

SHE:002788 China Pharmaceutical Retailers

Market Cap

$805.60 Million

CN¥5.51 Billion CNY

Market Cap Rank

#10232 Global

#2964 in China

Share Price

CN¥14.17

Change (1 day)

+0.28%

52-Week Range

CN¥7.99 - CN¥27.49

All Time High

CN¥22328.40